Cameco Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Cameco Corp reported revenue of $3.5B (+11.0% year on year) and net income of $589.5M (+243.1% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenue | $3.5B | $3.1B | $2.6B | $1.9B |
| Cost of products and services sold | $2.2B | $2.1B | $1.8B | $1.5B |
| Depreciation Expense | $293.1M | $280.7M | $220.3M | $177.4M |
| Cost of sales | $2.5B | $2.4B | $2.0B | $1.6B |
| Gross profit | $970.3M | $782.6M | $561.7M | $233.3M |
| Administrative cost | $311.3M | $253.2M | $245.5M | $172.0M |
| Exploration | $27.6M | $19.4M | $17.6M | $10.6M |
| Research and Development Expense | $38.5M | $36.5M | $21.0M | $12.2M |
| Other operating income | ($28.3M) | ($37.7M) | ($7.5M) | $22.9M |
| Loss on disposal of assets | $3.1M | $1.0M | $2.2M | $514.0K |
| Earnings from operations | $618.1M | $510.1M | $282.9M | $15.1M |
| Finance costs | ($115.2M) | ($147.2M) | ($115.9M) | ($85.7M) |
| Gains (losses) on derivatives | $95.0M | ($183.1M) | $37.8M | ($72.9M) |
| Interest Income | $23.2M | $21.2M | $111.7M | $37.5M |
| Share of earnings (loss) from equity-accounted investees | $216.4M | ($10.8M) | $154.5M | $94.0M |
| Foreign exchange gains (losses) | ($61.7M) | $65.5M | — | — |
| Other income | $1.5M | $975.0K | $16.2M | $96.9M |
| Earnings before income taxes | $777.3M | $256.7M | $487.2M | $84.8M |
| Income tax expense | $187.7M | $84.9M | $126.3M | ($4.5M) |
| Net earnings | $589.5M | $171.8M | $360.8M | $89.3M |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and Cash Equivalents | $1.1B | $600.5M | $566.8M | $1.1B |
| Short-term investments | $99.6M | — | $0 | $1.1B |
| Accounts Receivable | $360.3M | $346.8M | $422.3M | $183.9M |
| Current tax assets | $12.0M | $2.6M | $974.0K | $1.1M |
| Inventory | $844.0M | $826.9M | $692.3M | $664.7M |
| Supplies and prepaid expenses | $169.3M | $145.4M | $149.4M | $157.9M |
| Current portion of long-term debt | $39.1M | $1.1M | $10.2M | $32.2M |
| Total current assets | $2.6B | $1.9B | $1.8B | $3.3B |
| Net book value | $3.3B | $3.3B | $3.4B | $3.5B |
| Intangible assets | $36.2M | $39.8M | $43.6M | $47.1M |
| Net | $647.2M | $595.9M | $613.8M | $595.5M |
| Investment in equity-accounted investees | $3.0B | $3.2B | $3.2B | $211.0M |
| Deferred Tax Assets, Non-Current | $666.5M | $843.1M | $892.9M | $984.1M |
| Total non-current assets | $7.7B | $8.0B | $8.1B | $5.3B |
| Total assets | $10.3B | $9.9B | $9.9B | $8.6B |
| Accounts Payable | $871.4M | $619.0M | $577.5M | $374.7M |
| Current tax liabilities | $16.5M | $21.2M | $24.1M | $6.5M |
| Current portion of long-term debt | $0 | $285.7M | $499.8M | — |
| Current portion of other liabilities | $134.7M | $221.8M | $48.5M | $131.3M |
| Current | $47.6M | $38.0M | $39.1M | $48.3M |
| Total current liabilities | $1.1B | $1.2B | $1.2B | $560.8M |
| Long-term debt | $996.3M | $995.6M | $1.3B | $997.0M |
| Other liabilities | $378.0M | $363.5M | $343.4M | $216.2M |
| Provisions | $953.4M | $997.8M | $1.0B | $1.0B |
| Total non-current liabilities | $2.3B | $2.4B | $2.7B | $2.2B |
| Share capital | $2.9B | $2.9B | $2.9B | $2.9B |
| Contributed surplus | $211.4M | $210.8M | $215.7M | $224.7M |
| Retained earnings | $3.6B | $3.1B | $3.0B | $2.7B |
| Accumulated Other Comprehensive Income | $144.9M | $118.9M | ($15.3M) | $34.7M |
| Total shareholders' equity attributable to equity holders | $6.9B | $6.4B | $6.1B | $5.8B |
| Noncontrolling Interest | $15.0K | $26.0K | $4.0K | $11.0K |
| Total shareholders' equity | $6.9B | $6.4B | $6.1B | $5.8B |
| Total liabilities and shareholders' equity | $10.3B | $9.9B | $9.9B | $8.6B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net earnings | $589.5M | $171.8M | $360.8M | $89.3M |
| Depreciation Expense | $293.1M | $280.7M | $220.3M | $177.4M |
| Deferred sales | ($24.7M) | $61.2M | ($21.5M) | $43.5M |
| Unrealized losses (gains) on derivatives | ($145.8M) | $149.6M | ($61.7M) | $82.6M |
| Share-based compensation | $9.7M | $6.8M | $3.7M | $3.3M |
| Loss on disposal of assets | $3.1M | $1.0M | $2.2M | $514.0K |
| Interest Expense | $115.2M | $147.2M | $115.9M | $85.7M |
| Finance income | ($23.2M) | ($21.2M) | ($111.7M) | ($37.5M) |
| Share of loss (earnings) from equity-accounted investees | ($216.4M) | $10.8M | ($154.5M) | ($94.0M) |
| Other income | ($1.5M) | ($307.0K) | ($16.2M) | ($96.9M) |
| Foreign exchange (gains) losses | $61.7M | ($65.5M) | — | — |
| Other operating income | ($28.3M) | ($37.7M) | ($7.5M) | $22.9M |
| Income tax expense | $187.7M | $84.9M | $126.3M | ($4.5M) |
| Interest received | $23.2M | $21.2M | $113.8M | $35.4M |
| Income taxes paid | ($90.2M) | ($38.5M) | $70.4M | ($1.5M) |
| Dividends from equity-accounted investees | $446.7M | $185.4M | $113.6M | $117.7M |
| Other operating items | $208.5M | ($52.2M) | ($65.9M) | ($119.4M) |
| Net cash provided by operations | $1.4B | $905.3M | $688.1M | $304.6M |
| Additions to property, plant and equipment | ($333.0M) | ($211.6M) | ($153.6M) | ($143.4M) |
| Increase in short-term investments | ($99.6M) | $0 | $1.1B | ($1.0B) |
| Decrease (increase) in long-term receivables, investments and other | ($1.1M) | $4.8M | $1.0M | ($2.0M) |
| Proceeds from sale of property, plant and equipment | $245.0K | $377.0K | $69.0K | $780.0K |
| Net cash used in investing | ($433.5M) | ($206.4M) | ($2.0B) | ($1.3B) |
| Increase in long-term debt | $0 | $497.0M | $816.6M | — |
| Decrease in long-term debt | ($285.2M) | ($1.0B) | — | — |
| Interest paid | ($52.6M) | ($88.8M) | ($40.8M) | ($38.9M) |
| Shares issued, stock option plan | 2.2M | 16.7M | 27.5M | 9.6M |
| Lease principal payments | ($2.7M) | ($2.1M) | ($2.4M) | ($2.9M) |
| Dividends paid | ($104.5M) | ($69.6M) | ($52.1M) | ($51.9M) |
| Net cash used in financing | ($442.9M) | ($688.4M) | $748.8M | $869.3M |
| Increase in cash and cash equivalents, during the year | $532.0M | $10.4M | ($607.9M) | ($117.0M) |
| Net Change in Cash | ($17.6M) | $23.2M | $31.0M | $13.2M |
| Cash and cash equivalents, beginning of year | $600.5M | $566.8M | $1.1B | $1.2B |
| Cash and cash equivalents, end of year | $1.1B | $600.5M | $566.8M | $1.1B |
| Cash | $805.9M | $204.7M | $229.7M | $701.8M |
| Cash equivalents | $309.0M | $395.7M | $337.1M | $441.9M |
| Cash and cash equivalents | $1.1B | — | — | — |
Cameco Corp score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.